Zaid, Mohamed
Bajaj, Nimit
Burrows, Hannah
Mathew, Ryan
Dai, Annie
Wilke, Christopher T.
Palasi, Stephen
Hergenrother, Ryan
Chung, Caroline
Fuller, Clifton D.
Phan, Jack
Gunn, G. Brandon
Morrison, William H.
Garden, Adam S.
Frank, Steven J.
Rosenthal, David I.
Andersen, Michael
Otun, Adegbenga
Chambers, Mark S.
Koay, Eugene J.
Funding for this research was provided by:
Andrew Sabin Family Foundation
Sheikh Ahmed Center for Pancreatic Cancer Research
Institutional Funds from The University of Texas MD Anderson Cancer Center
GE Healthcare
Center for Advanced Biomedical Imaging
Project Purple
National Cancer Institute (Cancer Center Support (Core) Grant CA016672)
National Institutes of Health (U54CA210181-01, U54CA143837, U01CA196403, 1R01DE025248-01/R56DE025248-01, 1R01CA214825-01, 1R01CA218148-01, P30CA016672, P50 CA097007-10)
National Science Foundation (NSF 1557679)
Elekta AB
Article History
Received: 14 June 2019
Accepted: 9 August 2019
First Online: 19 August 2019
Ethics approval and consent to participate
: This study was approved by the institutional review board (IRB) under protocol number (2017–0269). Written consents were obtained from the study participants.
: Not applicable.
: Drs. Chung, Wilke, Fuller, Zaid, and Koay have a pending patent for the 3D printing process. We otherwise have no conflicts of interest to disclose.